AMGEN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2022. Key results include: Total revenues decreased 1% to $6.7...

Related Keywords

Germany ,Puerto Rico ,Japan ,United States ,Philadelphia ,Pennsylvania ,Japanese ,America ,American ,Jessica Akopyan ,Roberta Bradway ,Provention Bio ,Davidm Reese ,Instagram ,Amgen ,National Cancer Institute ,Research Development ,Astrazeneca ,Therapeutics Inc ,Arrakis Therapeutics Inc ,Teneobio Inc ,World Congress On Insulin Resistance ,Regeneron Pharmaceuticals Inc ,Plexium Inc ,Alexion Pharmaceuticals Inc ,Exchange Commission ,Biomedicines Inc ,Japanese Ministry Of Health ,European Society For Medical Oncology ,Linkedin ,American Society Of Clinical Oncology ,Twitter ,American Heart Association Scientific Sessions ,Eastern Cooperative Oncology Group ,European Union ,Kyowa Kirin Co Ltd ,Research Development Acquired ,Repatha On China National Reimbursement Drug List ,Beigene Ltd ,Most Sustainable Companies ,Cancer Research Group ,Youtube ,Amgen Inc ,American College Of Radiology Imaging Network ,Chemocentryx Inc ,National Reimbursement Drug List ,Average Selling Price ,Sales Detail ,Operating Margin ,Tax Rate ,Operating Expenses ,Acquired In Process Research ,Five Prime Therapeutics ,Diluted Shares ,Quarter Product ,World Congress ,Insulin Resistance ,Cardiovascular Disease ,Hybrid Conference ,Japanese Ministry ,Related Adverse Events ,Cooperative Oncology Group ,American College ,Radiology Imaging Network ,Clinical Oncology ,European Society ,Medical Oncology ,Janssen Pharmaceutica ,Regeneron Pharmaceuticals ,Alexion Pharmaceuticals ,Accepted Accounting Principles ,Free Cash Flow ,Total Revenues Adjusted ,Foreign Currency Impact ,Revenues Adjusted ,Dow Jones Industrial Average ,Generate Biomedicines ,Arrakis Therapeutics ,Balance Sheets ,Foreign Currency ,Year Ending December ,Rate Guidance ,